Blueshield v. Office of the Insurance Commissioner

¶1

Van Deren, A.C.J.

— Regence Blueshield appeals the trial court’s decision that the Office of the Insurance Commissioner (OIC) was justified when it disapproved of Regence’s proposed pharmacy rider, form RBS-56, because the contract did not comply with the diabetes cost reduction act of 1997 (DCRA).1 Regence argues that (1) annual benefit limits are a permissible cost-sharing provision under the statute’s plain language and (2) its statutory interpretation is correct in light of ejusdem generis,2 legislative history, case law, and other authority. Holding that the proposed pharmacy rider is…